Asciminib Demonstrates Preserved Vascular and Endothelial Function Supporting a Favourable Cardiovascular Safety Profile

P.R. reports consulting fees from: Pfizer, AstraZeneca, Novartis, Lilly, BMS, Janssen; payment or honoraria for lectures, presentations, speakers' bureau, manuscript writing or educational events from: Pfizer, Novartis, Janssen, AstraZeneca; support for attending meetings and/or travel from Pfizer, Novartis; grants or contracts from any entity: Pfizer, Novartis. A.G-P., S.P., A.S., S.S., A.S.A., D.L-L., R.K., O.W. and G.G.: declare no conflicts of interest regarding the work described in this paper. The data that support the findings of this study are available from the corresponding author upon reasonable request.